WGS
GeneDx Holdings Corp. (WGS)
NASDAQ · Healthcare
GeneDx Holdings Corp. annual/quarterly revenue history and growth rate from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- GeneDx Holdings Corp. revenue for the quarter ending March 31, 2026 was 102.3 M, a 17.38% increase year-over-year.
- GeneDx Holdings Corp. revenue for the twelve months ending March 31, 2026 was 408.8 M, a 55.37% increase year-over-year.
- GeneDx Holdings Corp. annual revenue for 2025 was 427.5 M, a 39.97% increase from 2024.
- GeneDx Holdings Corp. annual revenue for 2024 was 305.4 M, a 50.79% increase from 2023.
- GeneDx Holdings Corp. annual revenue for 2023 was 202.6 M, a 13.69% decrease from 2022.
- GeneDx Holdings Corp. annual revenue for 2022 was 234.7 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
GeneDx Holdings Corp. Earnings — FAQ
GeneDx Holdings Corp. (WGS) earnings over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see WGS's earnings history?
The chart and table above show GeneDx Holdings Corp.'s earnings by year and by quarter, including the growth rate.